Scientists hunt for clues to tame transplant side effects
NCT ID NCT02194868
Summary
This study aimed to understand how the body's immune system rebuilds itself after a stem cell transplant for blood cancers. Researchers followed 57 patients to see if measuring certain immune cells could predict serious complications like graft-versus-host disease (GVHD) or infections. The goal was to gather knowledge to help doctors better manage transplant outcomes in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Necker
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.